UPDATE 1-Amgen's bone drug succeeds in late-stage study

Sept 1 (Reuters) - Amgen Inc said its experimental bone drug was found to be more effective than an already marketed drug in a late-stage study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.